Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    CBRNE

    CBRN Medical Countermeasures Clinical Studies Network

    By Global Biodefense StaffMarch 18, 2013
    Share
    Facebook LinkedIn Reddit Email

    The Biomedical Advanced Research and Development Authority (BARDA) is seeking to establish a Medical Countermeasure Clinical Studies Network composed of contract research organizations to facilitate vaccine and therapeutic development for pandemic influenzas and chemical, biological, nuclear and radiological (CBRN) threats. 

    The proposed contracts will establish a network of providers to satisfy the clinical service requirements of BARDA and complement efforts of the National Institute of Allergy and Infectious Diseases (NIAID). 

    Awardees will provide clinical research services including full service capabilities to execute a clinical trial as a service to BARDA. These studies may be Phase 1, 2, 3, or 4 or combinations of these Phases. Clinical research services may include, but are not limited to the following components:

    Contracts may also contain preparedness and response task components that require contractors to be at the ready for urgent clinical trials in the case of a public health medical emergency. 

    “Awardees will support targeted clinical studies relevant to BARDA’s vision to create a nation with the capability to respond quickly and effectively to deliberate, natural and emerging threats by providing a range of clinical study services that can be used by BARDA and development partners of BARDA,” states the announcement.

    An official request for proposals is estimated to begin on March 30, 2013, with proposals being due May 14, 2013.  Multiple awards may result from the solicitation with an estimated award date of September 2013. 

    Further details are available under Solicitation Number: RFP-13-100-SOL-00008.

    ASPR BARDA HHS Request for Proposals Vaccine News
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleBiodefense Headlines – March 17, 2013
    Next Article NAMRU-3 Researchers Work in Bulgaria to Track Hantavirus

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    SOREX Brings Top CBRNE Units to Dugway Proving Ground

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy